Millipore adds water purification system for ion chromatography
The system improves baseline stability and reduces downtime in Dionex IC equipment.
Millipore of Billerica, MA, US, says ultrapure water from the ICW-3000 system increases the precision of IC analyses.
The ICW-3000 system provides a continual flow of ultrapure water to the eluent generator and regenerant lines of the suppressor. This reduces the carbonate content in the water - sharply decreasing contamination risks and improving experiment reproducibility, while also removing the need for helium. The water system also eliminates the need for eluent preparation and the instrument downtime that occurs when filling eluent bottles.
With only two tubes and one power cord to connect, the system simple to install. Everyday use is also easy. The user just fills the system's 10-litre tank with pure water in order to produce a constant flow of ultrapure water for the IC system. The ICW-3000 system is remote-controlled by the Dionex IC system and both systems are fully compatible.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing
Read morePrecise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing]()
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing
Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Manufacturing
![Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India]()
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India
The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![From speed to strategy: how UK life sciences should respond to China’s rise]()
From speed to strategy: how UK life sciences should respond to China’s rise
A group of biotech founders, big pharma leaders, clinical and CMC specialists, and CDMO executives gathered at a recent dinner sponsored by AsymChem to discuss a question now sitting in many boardrooms: what is China’s maturing biopharma ecosystem doing to the global industry, and how should UK companies respond?